Scott J. Goebel

3.0k total citations · 1 hit paper
30 papers, 2.4k citations indexed

About

Scott J. Goebel is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Scott J. Goebel has authored 30 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 10 papers in Virology. Recurrent topics in Scott J. Goebel's work include Poxvirus research and outbreaks (10 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Animal Virus Infections Studies (7 papers). Scott J. Goebel is often cited by papers focused on Poxvirus research and outbreaks (10 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Animal Virus Infections Studies (7 papers). Scott J. Goebel collaborates with scholars based in United States, Canada and Switzerland. Scott J. Goebel's co-authors include Enzo Paoletti, Gerard P. Johnson, Marion E. Perkus, Stephen W. Davis, Paul S. Masters, Elizabeth Norton, T R Barnett, James J. Elting, Jill Taylor and Raj Kalkeri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and Journal of Virology.

In The Last Decade

Scott J. Goebel

29 papers receiving 2.4k citations

Hit Papers

The complete DNA sequence of vaccinia virus 1990 2026 2002 2014 1990 200 400 600

Peers

Scott J. Goebel
Ahmed A. Azad Australia
Jerry P. Weir United States
Stéphane Hausmann Switzerland
Sue E. Delos United States
Hans G. Heine Australia
Robert A. Olmsted United States
Ahmed A. Azad Australia
Scott J. Goebel
Citations per year, relative to Scott J. Goebel Scott J. Goebel (= 1×) peers Ahmed A. Azad

Countries citing papers authored by Scott J. Goebel

Since Specialization
Citations

This map shows the geographic impact of Scott J. Goebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott J. Goebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott J. Goebel more than expected).

Fields of papers citing papers by Scott J. Goebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott J. Goebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott J. Goebel. The network helps show where Scott J. Goebel may publish in the future.

Co-authorship network of co-authors of Scott J. Goebel

This figure shows the co-authorship network connecting the top 25 collaborators of Scott J. Goebel. A scholar is included among the top collaborators of Scott J. Goebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott J. Goebel. Scott J. Goebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Awasthi, Mayanka, Anthony Macaluso, Scott J. Goebel, et al.. (2023). Immunogenicity and Tolerability of a SARS-CoV-2 TNX-1800, a Live Recombinant Poxvirus Vaccine Candidate, in Syrian Hamsters and New Zealand White Rabbits. Viruses. 15(10). 2131–2131. 2 indexed citations
2.
Awasthi, Mayanka, Anthony Macaluso, Fusataka Koide, et al.. (2023). Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman Primates. Vaccines. 11(11). 1682–1682. 3 indexed citations
3.
Kalkeri, Raj, et al.. (2020). SARS-CoV-2 Shedding from Asymptomatic Patients: Contribution of Potential Extrapulmonary Tissue Reservoirs. American Journal of Tropical Medicine and Hygiene. 103(1). 18–21. 29 indexed citations
4.
Snyder, Beth A., Scott J. Goebel, Fusataka Koide, Roger G. Ptak, & Raj Kalkeri. (2017). Synergistic antiviral activity of Sofosbuvir and type‐I interferons (α and β) against Zika virus. Journal of Medical Virology. 90(1). 8–12. 24 indexed citations
5.
Koide, Fusataka, Scott J. Goebel, Beth A. Snyder, et al.. (2016). Development of a Zika Virus Infection Model in Cynomolgus Macaques. Frontiers in Microbiology. 7. 2028–2028. 76 indexed citations
6.
Goebel, Scott J., Beth A. Snyder, Timothy J. Sellati, et al.. (2016). A sensitive virus yield assay for evaluation of Antivirals against Zika Virus. Journal of Virological Methods. 238. 13–20. 33 indexed citations
7.
Koetzner, Cheri A., Lili Kuo, Scott J. Goebel, et al.. (2010). Accessory Protein 5a Is a Major Antagonist of the Antiviral Action of Interferon against Murine Coronavirus. Journal of Virology. 84(16). 8262–8274. 35 indexed citations
8.
Goebel, Scott J., Jill Taylor, & Paul S. Masters. (2004). The 3′ cis -Acting Genomic Replication Element of the Severe Acute Respiratory Syndrome Coronavirus Can Function in the Murine Coronavirus Genome. Journal of Virology. 78(14). 7846–7851. 48 indexed citations
9.
Goebel, Scott J., et al.. (2003). Characterization of the RNA Components of a Putative Molecular Switch in the 3′ Untranslated Region of the Murine Coronavirus Genome. Journal of Virology. 78(2). 669–682. 104 indexed citations
10.
Johnson, Gerard P., Scott J. Goebel, & Enzo Paoletti. (1993). An Update on the Vaccinia Virus Genome. Virology. 196(2). 381–401. 113 indexed citations
11.
Johnson, Gerard P., et al.. (1991). Vaccinia virus encodes a protein with similarity to glutaredoxins. Virology. 181(1). 378–381. 34 indexed citations
12.
Perkus, Marion E., Scott J. Goebel, Stephen W. Davis, et al.. (1991). Deletion of 55 open reading frames from the termini of vaccinia virus. Virology. 180(1). 406–410. 91 indexed citations
13.
Goebel, Scott J., et al.. (1990). A DNA ligase gene in the copenhagen strain of vaccinia virus is nonessential for viral replication and recombination. Virology. 179(1). 267–275. 45 indexed citations
14.
Tartaglia, James, et al.. (1990). Nucleotide sequence analysis of a 10.5 kbp HindIII fragment of fowlpox virus: relatedness to the central portion of the vaccinia virus HindIII D region. Journal of General Virology. 71(7). 1517–1524. 26 indexed citations
15.
Perkus, Marion E., Scott J. Goebel, Stephen W. Davis, et al.. (1990). Vaccinia virus host range genes. Virology. 179(1). 276–286. 160 indexed citations
16.
Goebel, Scott J., et al.. (1990). The complete DNA sequence of vaccinia virus. Virology. 179(1). 247–266. 745 indexed citations breakdown →
17.
Taylor, Jill, et al.. (1990). Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. Journal of Virology. 64(4). 1441–1450. 100 indexed citations
18.
Guo, Peixuan, Scott J. Goebel, Marion E. Perkus, et al.. (1990). Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity. Journal of Virology. 64(5). 2399–2406. 44 indexed citations
20.
Kamarck, Michael E., James J. Elting, John Hart, et al.. (1987). Carcinoembryonic antigen family: expression in a mouse L-cell transfectant and characterization of a partial cDNA in bacteriophage lambda gt11.. Proceedings of the National Academy of Sciences. 84(15). 5350–5354. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026